1. Home
  2. CREX vs MDXH Comparison

CREX vs MDXH Comparison

Compare CREX & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$3.95

Market Cap

39.1M

Sector

Technology

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.61

Market Cap

41.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREX
MDXH
Founded
N/A
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
41.1M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
CREX
MDXH
Price
$3.95
$0.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
33.2K
1.1M
Earning Date
04-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
N/A
EPS
N/A
N/A
Revenue
$18,437,000.00
N/A
Revenue This Year
$81.98
$30.78
Revenue Next Year
$14.82
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$2.19
$0.51
52 Week High
$4.42
$5.33

Technical Indicators

Market Signals
Indicator
CREX
MDXH
Relative Strength Index (RSI) 51.19 12.70
Support Level $3.52 N/A
Resistance Level $3.81 $2.30
Average True Range (ATR) 0.26 0.10
MACD 0.00 -0.01
Stochastic Oscillator 63.11 17.54

Price Performance

Historical Comparison
CREX
MDXH

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: